TOP特許意匠商標
商標ウォッチ Twitter
公開日2025-03-05
公報種別公開国際商標公報
国際登録番号1830675
国際登録日2024-10-09
区分第1類(化学品),第5類(薬剤),第40類(製造・加工),第42類(科学・技術)
商品役務Modified cells, in particular genetically modified iPS (induced pluripotent stem) cells and differentiated cells derived therefrom, for research or scientific purposes; cell cultures, cell culture systems and cryopreserved genetically modified iPS cells for scientific and industrial research purposes; cell cultures, and cryopreserved cells iPS cells other than for medical or veterinary use; compositions and materials for scientific use, including cell culture agents for use in the biotechnology industry and cell material for use in combination with human cells, including genetically modified iPS or differentiated stem cells.,Modified cells, in particular genetically modified iPS (induced pluripotent stem) cells or differentiated cells derived therefrom, for medical or veterinary use; cell cultures and cell culture systems, and cryopreserved pluripotent stem cells for medical or veterinary use; genetically modified iPS (induced pluripotent stem) cells for use in generating other cells for therapeutic purposes; cell cultures and cell culture systems, and cryopreserved genetically modified pluripotent stem cells for sub cultivation of cells.,Custom manufacturing of iPS derived cells, and iPS derived cell therapy and manufacturing processes for others, including manufacturing in GMP-based facilities; custom manufacture of therapeutic cells, medicines, cell therapies and gene edited cell therapies for others, including manufacturing in GMP-based facilities; custom manufacture of cellular therapies全 31 件を表示, including manufacturing in GMP-based facilities; manufacturing of cell lines (modified cells with specific genetic edits) for use in generating other cells.,Research and testing of cell-based products, in particular therapeutic products; research, optimization and testing of cell production processes; laboratory research in the field of biotechnology using genetically modified iPS (induced pluripotent stem) cells or differentiated cells derived therefrom; Scientific research, design and development of scientific cell culture, cell therapy or gene edited cell therapy; Scientific research, design and development of cell culture, cell therapy or gene edited cell therapy, manufacturing systems and manufacturing processes for others; platform as a service [Paas] in the field of cell therapy, and cell therapy development; providing temporary use of a technological platform for the manufacturing of cell-based therapies, including technology, processes, and data analytics capabilities for process optimization and quality control.
基礎出願番号018984056
基礎出願日2024-02-07
基礎出願国EM
出願人Celyntra Therapeutics SA
OCRテキストぎん 芝 Sき 少 多N 人N Allo Chassis
OCRテキスト2
OCRについて
この商標をJ-PlatPatで参照する
Flag Counter

関連商標

BioAtlantis Limited
SuperFifty
9か月前
Liquid Casing, Inc.
LIQUIDWELLSHIELD
2か月前
LG Corp.
Smile,On! LG
2か月前
BOPLAN BV
EXTRILENE
7か月前
Borregaard AS
as LIGNOBRITE
3か月前
Borregaard AS
LIGNOBRITE
3か月前
JIANGSU LOPAL TECH CO., LTD.
龙蟠
6か月前
Sequrna AB
SEQURNA
2か月前
ADDINOL Lube Oil GmbH
3か月前
Meteor Biotech Co., Ltd.
3か月前
Vedanta Resources Limited
VEDANTANICO
3か月前
Oy Karl Fazer Ab
3か月前
Errecom S.p.a.
3か月前
STANDING OVATION
StandingOvation-AdvancedCasein
3か月前
One Innovation Labs, LLC
3か月前
Ethris GmbH
3か月前
NEKTIUM PHARMA S.L.
3か月前
Zero Petroleum Limited
3か月前
GELITA AG
3か月前
個人
3か月前
GELITA AG
3か月前
KD Finechem Co., Ltd.
3か月前
SEDERMA
3か月前
BLUE ORIGIN MANAGEMENT CONSULTANT PTE. LTD.
3か月前
HYDROGENIOUS LOHC TECHNOLOGIES GMBH
3か月前
CIRCA GROUP AS
Cyrene
10か月前
Proxag
3か月前
SI Group, Inc.
3か月前
CARBIOS
CARBIOSACTIVE
3か月前
L’AIR LIQUIDE, SOCIETE ANONYME POUR L’ETUDE ET L’EXPLOITATION DES PROCEDES GEORGES CLAUDE
SUBLEEM
3か月前
LVMH FRAGRANCE BRANDS
Collagiv-ActTechnology
3か月前
AQVA Holding AG
PEAQ
3か月前
LG Corp.
LLG
3か月前
Glanbia Nutritionals Limited
IMMULOX
3か月前
Holcim AG
ELEVATE
3か月前
Seamless Therapeutics GmbH
seamless
3か月前
続きを見る